Danaher Corporation (BMV:DHR)

Market Cap	2.91T
Revenue (ttm)	445.44B
Net Income (ttm)	64.30B
Shares Out	n/a
EPS (ttm)	89.33
PE Ratio	45.28
Forward PE	28.07
Dividend	24.18 (0.58%)
Ex-Dividend Date	Dec 26, 2025

Volume	12
Average Volume	295
Open	4,056.65
Previous Close	4,134.08
Day's Range	4,056.65 - 4,056.65
52-Week Range	3,358.00 - 5,100.00
Beta	0.92
RSI	49.77
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD